Solid World Group S.p.A. (IT:S3D) has released an update.
SolidWorld Group S.p.A. is set to hold an Extraordinary Shareholders’ Meeting on November 13, 2024, to discuss a proposed capital increase aimed at boosting its biomedical business and expanding its international sales network. The company plans to raise up to €5 million through a rights issue, primarily focusing on enhancing production capacity and introducing the Electrospider bio-printer globally. This move follows a successful capital increase in July and highlights SolidWorld’s commitment to growth in the 3D design and bio-manufacturing sectors.
For further insights into IT:S3D stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
